RNA interference (RNAi) is a widely adopted tool for loss-of-function studies but RNAi results only have biological relevance if the reagents are appropriately mapped to genes.
Introduction
RNA interference (RNAi) is an effective tool to study gene function. In particular,
genome-scale RNAi screens in mammalian and Drosophila cultured cells, as well as in vivo in
Drosophila and C. elegans, have made contributions to a number of areas of study (BOUTROS and AHRINGER 2008; DIETZL et al. 2007; KAMATH et al. 2003; MOHR et al. 2010; MOHR and PERRIMON 2012; PERRIMON et al. 2010; QU et al. 2011) . RNAi screening is dependent not only on the availability of RNAi reagents but also on accurate information regarding the predicted gene targets of the reagents. Large-scale RNAi libraries are available for a number of model systems. Although different types of RNAi reagents are used in different systems, there is a common and significant need to keep RNAi reagent annotations up-to-date with new genome assemblies and gene annotations.
A large number of cell-based RNAi screens have been performed using various genome-scale RNAi reagent libraries (MOHR et al. 2010) . RNAi reagents for Drosophila cells are usually long (~100-500 bp) double-stranded RNAs (dsRNAs) made by PCR using a genomic or cDNA template, followed by in vitro transcription. In the cell, dsRNAs are processed by the endogenous RNAi machinery, generating active RNAi reagents, i.e. small dsRNA segments typically 20-22 bp in length with a 2 bp 3' overhang (CLEMENS et al. 2000; HAMMOND et al. 2000) . In Drosophila, dsRNAs can be easily introduced into cultured cells (CLEMENS et al. 2000; HAMMOND et al. 2000) . Several large-scale facilities, including the Drosophila RNAi Screening Center (DRSC) at Harvard Medical School, Boutros lab at German Cancer Research Center (DKFZ), RNAi Core at New York University, and Sheffield RNAi Screening Facility (SRSF), support Drosophila cell-based RNAi screening and offer genome-wide libraries with multiple dsRNAs-per-gene coverage. For mammalian cells, RNAi screens are done using synthesized short interfering RNAs (siRNAs), endoribonuclease-prepared short interfering RNAs (esiRNAs), or plasmid-or viral-encoded short hairpin RNAs (shRNAs) (KITTLER et al. 2007; MICKLEM and LORENS 2007; ROOT et al. 2006) . Similar to Drosophila cell screens, mammalian screens are typically performed in individual labs or in conjunction with one of several academic screening facilities that provide automation and database support for screens.
RNAi reagents have also been developed for in vivo screens in various systems. In C.
elegans, RNAi is systemic, and gene expression can be knocked down efficiently by feeding worms with bacteria expressing a long dsRNA (FRASER et al. 2000) . A genome-scale RNAi feeding library is available (KAMATH et al. 2003) and widely used for functional studies. For Drosophila, in vivo RNAi relies on transgenic flies carrying RNAi transgenes that can be combined with the Gal4/UAS system for developmental, stage-and/or tissue-specific knockdown (G. Dietzl, D. Chen et al, Nature 2007) . Drosophila in vivo RNAi reagents are either long dsRNA hairpins, for which gene fragments are cloned as an inverted repeat, or short hairpins synthesized as oligonucleotides and then cloned into an expression vector . Altogether, about 90% of annotated Drosophila genes are targeted by fly RNAi collections from Vienna Drosophila RNAi Center (VDRC), NIG RNAi Resources in Japan and Transgenic RNAi Project (TRiP) at Harvard Medical School (DIETZL et al. 2007; NI et al. 2009; NI et al. 2008; YAMAMOTO 2010) . Several large-scale transgenic RNAi screens have been successfully performed (reviewed in ) and numerous in vivo Drosophila RNAi projects are ongoing.
Obtaining meaningful results from RNAi-based studies is entirely reliant upon appropriate identification of the sequence-specific gene target(s) of the reagent. Target identification might appear to be a simple problem but this is not necessarily the case. Even though sequences associated with RNAi reagents are static (e.g. the sequences of oligonucleotides used to make a library do not change), the reference sequences and gene annotations, including gene boundaries, exon-intron boundaries and nomenclature, are constantly being updated. Re-evaluations of existing RNAi libraries have shown that by the time of re-analysis, a percentage of reagents do not target any gene or are no longer predicted to be specific QU et al. 2011 Off-target effects (OTEs) are also relevant to the annotation of RNAi reagents. OTEs are induced by unintended cross-hybridization between RNAi reagents and endogenous sequences other than the target (KULKARNI et al. 2006; MOFFAT et al. 2007) . As the sequences of gene and transcript change at each gene annotation release, annotation of potential OTEs can also change over time. Correcting for changes is not simply a matter of keeping up with new gene names and synonyms. Updates can change predictions as to the target gene, the number of predicted off-targets, isoform specificity, etc. As a result, it is critically important to regularly update the annotation of RNAi reagents and make this information readily accessible to the researchers who plan, execute and analyze RNAi-based experiments.
Several tools are available for the design of RNAi reagents, including SnapDragon for long dsRNAs (FLOCKHART et al. 2006; FLOCKHART et al. 2012) , DSIR for siRNAs (FILHOL et al. 2012; VERT et al. 2006) , and E-RNAi and NEXT-RNAi (ARZIMAN et al. 2005; for long dsRNAs and siRNAs. Nevertheless, a web-based tool that addresses the dynamic nature of gene annotation has not previously been available.
Although E-RNAi can be used to evaluate long dsRNAs and siRNAs, the reference gene information for Drosophila in E-RNAi is currently out of date (FlyBase release5.19 from July 2009). NEXT-RNAi was designed to be integrated into a backend design/annotation pipeline and there is not currently an openly accessible web-based user-interface for the approach. In addition, NEXT-RNAi does not distinguish between RNAi reagents generated from genome DNA versus cDNA templates, a feature that is relevant to accurate annotation.
To best support community needs, the ideal tool would be based on regular, automated retrieval of new genome assemblies and gene annotation releases. The ideal tool would also handle the dynamic nature of reagent collections via regular, automatic retrieval of new reagent information from major public resources. To meet these needs, we developed a tool that allows users to query existing RNAi reagents from various sources based on the current gene annotation. The tool also allows researchers to query up-to-date information regarding gene target using user-provided RNAi reagent sequences.
Materials and Methods

Data Sources
Reference gene information is downloaded from the following sources: FlyBase for 
Data Annotation Pipeline
The data annotation pipeline ( 
Software
The BLAST program from NCBI (ALTSCHUL et al. 1990 ) is among the research applications already installed on the Orchestra platform at Harvard Medical School. The BLAST parameters for virtual PCR: -W 10 -e 1 -G 5 -E 2; cutoff for virtual PCR: 100% identity; BLAST parameters for on-target/off-target searches: -W 14 -e 10 -G 5 -E 2 -F F; cutoff for on-target search: 27bp or longer with >=98% identify; cutoff for off-target search: 15bp alignment or longer. JBrowse was downloaded from jbrowse.org/install (SKINNER et al. 2009 ). More detailed information can be found at jbrowse.org/developer. Programs for reagent annotation were written in Perl and the user interface was developed using HTML, JavaScript, Java servlets and Lucene. A Perl program provided as part of the JBrowse download converts annotations from the GFF3 format to the JBrowse format.
Results and Discussion
Reference genes are 'moving targets' that change over time For Drosophila melanogaster, FlyBase is the primary resource of integrated genetic and genomic information, including up-to-date genome assemblies and gene annotations (FLYBASE-CONSORTIUM 2003) . Since the first assembly of the Drosophila melanogaster genome published in 2000, four subsequent genome assemblies, with the most recent one in February 2007, have occurred (CELNIKER et al. 2002; HOSKINS et al. 2007; MYERS et al. 2000) . In addition to updates to the genome assembly, there have been numerous updates since 2000 to gene annotations.
Particularly given the new availability of next-generation sequencing approaches, gene annotations continue to change, for example due to the addition of newly identified genes and newly identified isoforms of previously identified genes. Thus, despite the fact that Drosophila is arguably the best annotated genome among multi-cellular species, our knowledge of the fly genome and proteome continues to improve. Indeed, since the availability of the 5 th genome assembly (i.e. over that last six years or so), the FlyBase consortium has released 49 updates to Drosophila gene annotations.
Exemplifying the extent of changes, for the gene annotation release issued on September 7, 2012, 123 genes and 578 protein-coding transcripts were changed relative to the previous release. Moreover, the number and type of changes to gene annotations varies with each release. To obtain a more comprehensive picture of gene annotation changes, we looked at changes to the gene annotation over the period of one year (FlyBase version r5.34 vs 5.44).
On the gene level, 412 new genes were added, 12 genes were retired, and the genome location of 2287 genes was changed. On the transcript level, 3407 new transcripts were added, 833
transcripts were retired, and the specific sequences of 2902 transcripts were changed. Thus, for a Drosophila RNAi reagent designed at the beginning of this period, there is an approximately 30% chance that the sequence of the gene target had changed a year later. Given that the time from RNAi reagent design to availability of the reagent for experiments can be months, and the practical reality that many RNAi reagents are put to use several years after they were designed, these changes have a significant impact on RNAi reagent annotation. Notably, gene annotation changes can affect not just the on-target predictions for a given RNAi reagent but also the number of predicted off-target effects (OTEs) associated with a given reagent and/or whether or not it is predicted to target all isoforms of the target gene. For a summary of annotation changes in FlyBase and WormBase over the past five years, see supplemental table 1.
Dynamic annotation of RNAi reagents
When a large amount of information is involved (in this case, information surrounding the sequence and targets of RNAi reagents), the typical approach is to use a back-end database to store the information. At the DRSC, the backend storage is a relational MySQL database (FLOCKHART et al. 2006; in which a couple dozen tables are used to store information regarding gene annotations associated with DRSC and TRiP RNAi reagents.
Updating gene annotations as frequently as FlyBase releases updates is not trivial and as a result, such databases are usually out of sync with the most current release, a situation that is acceptable for most RNAi reagents but potentially misleading for a sub-set of reagents for which the corresponding gene annotations have changed significantly. Moreover, forever associating the RNAi reagent with its originally intended target might bias interpretation of RNAi results, even when information about alternative targets is also presented.
To address this issue, we developed a new strategy and developed a dynamic annotation tool that is 'blind' to the original target gene annotations, basing the final reports presented online solely on updated information. The tool, which we named UP-TORR for updated targets of RNAi reagents, daily and automatically accesses the ftp sites available at FlyBase, WormBase as well as RefSeq database at NCBI and whenever a new release is available, retrieves all of the new sequence and gene annotation information. Thus, at any given time, a query of UP-TORR will generate the most updated results available. For cell-based RNAi reagents from the DRSC and DKFZ as well as in vivo long hairpin reagents generated by VDRC and Ahringer lab, PCR primer sequences are aligned to the up-to-date genome assembly sequence, generating virtual PCR products. The sequences of these PCR products are then BLASTed against transcript sequences in order to identify the current on-target and offtarget predictions. The process is similar for in vivo long hairpin reagents generated by TRiP, except that for these, transcript sequences are used to generate the virtual PCR product, as the template used to generate these was cDNA rather than genomic DNA. For the in vivo long hairpin reagents generated by NIG, because most reagent sequences were assembled by endto-end sequencing, for these reagents we skip the virtual PCR step and go directly to BLASTing
RNAi sequences against transcript sequences. When a user enters a pair of primers for analysis, the user can specify if genomic DNA or transcript sequences should be used in the virtual PCR step. For shRNA reagents, both the 21 bp sense-strand and anti-strand sequences, which originated as synthetic oligonucleotides, can be directly BLASTed against transcript sequences (Fig. 1) .
During the reagent 'live re-annotation' process, UP-TORR is designed to answer the following questions. Using this tool, we re-annotated all the RNAi reagents generated at DRSC, DKFZ, VDRC, NIG and TRiP based on FlyBase release 5.49 (Table 1) . We found that a percentage of the reagents no longer met the original design goal. For example, within the TRiP shRNA collection, 3% of reagents were predicted at the time of our re-annotation with UP-TORR to target multiple genes. Some of these are due to high sequence similarity of the paralogous genes such as His1, His2A, His2B and His3 families respectively, making it impossible to design gene-specific RNAi reagents. Additionally, the Drosophila genome is more compact than the mammalian genome, and some genes are located close to each other or fully overlap on the genome as well as at the transcript level. For example, the genes cup and CG34310 are both located at 6663968-6674780 on the + strand of chromosome 2L. Their transcripts are also identical and the only difference is the protein-coding regions ( Fig. 2A) . In cases like this, it is impossible to design any RNAi reagent targeting one gene but not the other. Another example is eIF-2gamma and Su(var)3-9. These genes partially overlap on both the genome and transcript levels. TRiP reagent HMS00279 happened to target exons shared by the two genes; therefore, the library could be improved by targeting the regions specific to each gene (Fig. 2B ). In addition, 0.8% of reagents do not target any genes in the release we were testing. They aligned to introns (Fig. 2C) , inter-gene regions (Fig. 2D) or pseudogenes (Fig. 2E ) due to the changes in the intron-exon boundary, gene boundary or gene retirement.
Our comparison of FlyBase releases (r5.34 and r5.44) shows that 3407 new transcripts were added and 833 transcripts were removed. Thus, it is more likely that a new isoform will be added than that an existing isoform will be retired. An RNAi reagent may fail to target all isoforms even though it was initially designed to be isoform unspecific. According to FlyBase release 5.49, 38% of fly genes have more than one isoform. We found that 90% of TRiP shRNA reagents still target all isoforms whereas 6% target one or a subset of isoforms based on current isoform annotation. Some of these reagents are limited by the genes themselves, which lack exons common among all isoforms (Fig. 2F) , whereas others could be improved ( 
Online features of UP-TORR
To provide researchers with the most current and accurate annotation of RNAi reagents, we developed a freely accessible web-based application. To accommodate the full spectrum of community needs regarding reagent identification and live re-annotation, we have provided users with five different ways to query UP-TORR. After selecting the species (Drosophila, C.
elegans, mouse or human) from the appropriate menu tab, users can (1) (1), (2) and (3), in which an RNAi reagent is the input, UP-TORR returns a summary of all of the potentially targeted genes, including gene identifiers such as FlyBase FBgn number for fly and NCBI Entrez GeneID for other species, gene symbol, and gene isoform information, as well as the region and location of each isoform that is targeted. UP-TORR also reports the number of possible off-target genes, which is hyperlinked to detailed information about the genes (Fig. 3) . For query types (4) and (5) Finally, we note that when the output species is Drosophila or C. elegans, the output page from a DIOPT ortholog search (flyrnai.org/diopt) or DIOPT-DIST disease-gene ortholog search (flyrnai.org/diopt-dist) (HU et al. 2011) has been modified to include a button that carries the gene list forward from DIOPT or DIOPT-DIST to UP-TORR. We expect this should help facilitate identification of RNAi reagents relevant to conserved and disease-related genes.
Discussion
There is a necessary passage of time between the design of RNAi reagents and their use, as well as between design and analysis of results (and later re-interpretation of RNAi data, such as in meta-analyses) QU et al. 2011 (MULLER et al. 2008) . In addition, SNPs (CHEN et al. 2009 ), RNA editing (RODRIGUEZ et al. 2012 and chimeric transcripts (FRENKEL-MORGENSTERN et al. 2013) can complicate the prediction of the on-target as well as off-target genes of RNAi reagents. Nevertheless, UP-TORR is the first tool available to address the issue of genome annotation and RNAi sequences. Importantly, the tool provides up-to-date annotation for RNAi reagents targeting human (Fig. S1 ), mouse genes as well as for Drosophila and C.
elegans, and could easily be expanded to include more species. In the future, this tool might be applied to other methods (e.g. TALEs (CHRISTIAN et al. 2010) and CRISPRs (CONG et al. 2013)) for which gene annotation impacts interpretation of the reagents.
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